| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2007 | WO2006076284A3 AMINO-IMIDAZOLONES FOR THE INHIBITION OF ß-SECRETASE |
| 04/19/2007 | WO2006074928A3 Topical product for preventing and treating nappy rash |
| 04/19/2007 | WO2006074924A8 3,4,(5)-substituted tetrahvdropyridines |
| 04/19/2007 | WO2006073939A3 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate |
| 04/19/2007 | WO2006071955A3 Glufosfamide combination therapy |
| 04/19/2007 | WO2006071740A3 5ht2c receptor modulator compositions and methods of use |
| 04/19/2007 | WO2006070022A3 Medicaments containing selenium for the treatment of endothelial vascular diseases |
| 04/19/2007 | WO2006062931A3 Medical combinations |
| 04/19/2007 | WO2006060723A3 Methods for producing block copolymer/amphiphilic particles |
| 04/19/2007 | WO2006060199A3 Imidazole derivatives for the treatment of sexual dysfunction |
| 04/19/2007 | WO2006059764A3 Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 04/19/2007 | WO2006055869A3 Antibiotic compounds, compositions and medical uses |
| 04/19/2007 | WO2006047492A3 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 04/19/2007 | WO2006041808A8 Tafi inhibitors and their use to treat pulmonary fibrosis |
| 04/19/2007 | WO2006040178A9 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor |
| 04/19/2007 | WO2006039399A3 Staufen 1 (stau1) - mediated mrna decay |
| 04/19/2007 | WO2006035301A3 Erythromycin a derivatives as antibacterial agents |
| 04/19/2007 | WO2006034317A3 Chemical compounds |
| 04/19/2007 | WO2006033005A8 Thrombopoietin receptor agonists |
| 04/19/2007 | WO2006023844A3 Compositions and methods comprising proteinase activated receptor antagonists |
| 04/19/2007 | WO2006023703A3 Method for treating sleep related breathing disorders |
| 04/19/2007 | WO2006012779A8 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical |
| 04/19/2007 | WO2005120466A3 Sugar coatings and methods therefor |
| 04/19/2007 | WO2005115147A3 Hiv reverse transcriptase inhibitors |
| 04/19/2007 | WO2005105732A8 Substituted methyl aryl or heteroaryl amide compounds |
| 04/19/2007 | WO2005105088A3 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension |
| 04/19/2007 | WO2005097783A8 Thiocarbamoylprolines |
| 04/19/2007 | WO2005079367A3 Schizochytrium fatty acid synthase (fas) and products and methods related thereto |
| 04/19/2007 | WO2005077950A3 Medicaments with hm74a receptor activity |
| 04/19/2007 | WO2005076697A3 Cosmetic and pharmaceutical foam with solid matter |
| 04/19/2007 | WO2005074899A3 New compositions containing quinoline compounds |
| 04/19/2007 | WO2005056802A3 Materials and methods relating to cell cycle control |
| 04/19/2007 | WO2005011615A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070089176 Cytokine involved in epithelial-mesenchymal transition |
| 04/19/2007 | US20070088435 Nitrosation of a organosulfur polymer; coating medical equipment such as tubes, catheters |
| 04/19/2007 | US20070088165 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/19/2007 | US20070088163 Modulators of calcitonin and amylin activity |
| 04/19/2007 | US20070088159 Hydroxyalkyl cyclic diamine compounds |
| 04/19/2007 | US20070088158 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes |
| 04/19/2007 | US20070088090 Alpha-bulnesene, its preparation and its use |
| 04/19/2007 | US20070088089 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/19/2007 | US20070088088 Method for preventing or treating metabolic syndrome |
| 04/19/2007 | US20070088087 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 04/19/2007 | US20070088086 Method of using synthetic L-Se-methylselenocysteine as a nutriceutical and a method of its synthesis |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088084 Malic acid addition salts of terbinafine |
| 04/19/2007 | US20070088083 2-[3-(2-Chloro-4-fluorobenzoyl)ureido]phenoxyacetic acid, used for the treatment of non-insulin dependent diabetes and for reducing blood glucose levels; antidiabetic agents |
| 04/19/2007 | US20070088082 Polymorphic forms of ladostigil tartrate |
| 04/19/2007 | US20070088081 Polyamine conjugates as selective NMDA inhibitors and anti-cancer drugs |
| 04/19/2007 | US20070088080 Gsk-3 inhibitors isolated from marine organisms |
| 04/19/2007 | US20070088079 Prophylactic or therapeutic agent for sleep disorder |
| 04/19/2007 | US20070088078 Methods for managing adipocyte fat accumulation |
| 04/19/2007 | US20070088077 Appetite stimulation and reduction of weight loss in patients suffering from symptomatic hiv infection |
| 04/19/2007 | US20070088076 conjugated of a second-generation taxoid ( ortataxel or SB-T-1104( frag sheet) and an omega-3 fatty acid selected from docosahexanoic acid, eicosapentaenoic acid and alpha-linolenic acid for treting cancer |
| 04/19/2007 | US20070088075 used in studies of metabolism of drugs and toxic substances in humans and other animals; deuterated compounds are used in pharmaceutical research to investigate in vivo metabolic fate of compounds by evaluation of mechanism of action and metabolic-pathway of non deuterated parent compound; drug design |
| 04/19/2007 | US20070088074 Article of manufacture comprising aromatic amino acids isomers, analogs, or derivatives thereof to treat neurological disorders involving dysfunction of glutamatergic synaptic transmission |
| 04/19/2007 | US20070088073 Method for treating pain |
| 04/19/2007 | US20070088072 Method for treating pain |
| 04/19/2007 | US20070088071 3-[(3-Bromo-4-{(2S)-2-[(5-chloro-1-methyl-1H-indol-2-yl)carbonyl]heptyl}benzoyl)amino]propanoic acid and 3-[(3-Bromo-4-{(2R)-2-[(5-chloro-1-methyl-1H-indol-2-yl)carbonyl]heptyl}benzoyl)amino]propanoic acid; glucagon receptor antagonists; type 2 diabetes mellitus |
| 04/19/2007 | US20070088070 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance |
| 04/19/2007 | US20070088069 Novel imidazoles |
| 04/19/2007 | US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 04/19/2007 | US20070088067 Novel amidine compounds for treating microbial infections |
| 04/19/2007 | US20070088066 Metaxalone products, method of manufacture, and method of use |
| 04/19/2007 | US20070088065 Metaxalone products, method of manufacture, and method of use |
| 04/19/2007 | US20070088064 Pharmaceutical composition containing bicyclic type compounds |
| 04/19/2007 | US20070088063 Alzheimer's disease; bridged bicycloalkyl spirocyclic sulphonamide derivatives; oral administration |
| 04/19/2007 | US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects; |
| 04/19/2007 | US20070088061 use treating peroxysome proliferator-activated receptor gamma (PPAR gamma ) mediated diseases and conditions such as diabetes, insulin resistance; e.g. 2-(1,3-benzoxazol-2-ylamino)-3-(4-(2,3-dihydro-1,4-benzodioxin-6-ylmethoxy)phenyl)propionic acid |
| 04/19/2007 | US20070088060 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates |
| 04/19/2007 | US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
| 04/19/2007 | US20070088058 3-(1(S)(4-chlorobenzyl)-2(S)-((2-hydroxy-2-methyl-1-phenylpropyl)amino)propyl)-benzonitrile; obesity; potentiation; antagonists |
| 04/19/2007 | US20070088057 reconstitution times for certain bis(thio-hydrazide amide) disalts can be decreased considerably by lyophilizing and annealing the disalts in the presence of a crystalline bulking excipient under certain conditions; high water solubility; cancer |
| 04/19/2007 | US20070088056 Use of a pyrazole derivative for producing medicaments that are useful in preventing and treating chronic bronchitis and chronic obstructive bronchopneumopathy |
| 04/19/2007 | US20070088055 Process for producing 1-benzyl-4-[ (5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine or hydrochloride thereof |
| 04/19/2007 | US20070088054 Biphenyl derivatives |
| 04/19/2007 | US20070088053 Non-nucleoside reverse transcriptase inhibitors |
| 04/19/2007 | US20070088052 Sulfonamide derivatives as 5ht7 receptor antagonists |
| 04/19/2007 | US20070088051 Indolinones and their use as antiproliferative agents |
| 04/19/2007 | US20070088050 Mixture of particle sizes; dosage forms; high purity; extremely low heavy metal content |
| 04/19/2007 | US20070088049 Polymorphic forms of methyl (+)-(s) - alpha - (2-chlorophenyl)-6, 7-dihydrothieno [3,2-c]pyridine-5(4h) acetate hydrobromide, clopidogrel hydrobromide |
| 04/19/2007 | US20070088048 Clopidogrel salt and polymorphic forms thereof |
| 04/19/2007 | US20070088047 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088046 cerebral oxygenators and vasoregulators; antidepressant, cognition activator; sleep disorders; enantiomer mixture separated by HPLC; classical antidepressants resistance |
| 04/19/2007 | US20070088045 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 04/19/2007 | US20070088044 Quinazoline derivatives as antitumor agents |
| 04/19/2007 | US20070088043 Novel HDAC inhibitors |
| 04/19/2007 | US20070088042 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088041 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
| 04/19/2007 | US20070088040 ethyl 1-(2,4-dimethoxybenzyl)-7-(2-(S)-hydroxymethyl-pyrrolidin-1-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylate; 7-(2-aminomethylpyrrolidin-1-yl)-1-(2,4-dimethoxybenzyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-caboxylic acid; treating quinolone-resistant bacterial infections in a mammal |
| 04/19/2007 | US20070088039 Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function |
| 04/19/2007 | US20070088038 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| 04/19/2007 | US20070088037 Cancer and fibrotic diseases |
| 04/19/2007 | US20070088036 1-[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carbonitrile; -[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carboxylic acid methyl ester; deposited on a stent or stent-graft device |
| 04/19/2007 | US20070088035 Crystalline forms of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| 04/19/2007 | US20070088034 e.g. 5-oxo-5-phenyl-valeric acid 4-dimethylamino-4-phenyl-cyclohexyl)-amide; opioid receptor modulator; noradrenaline and serotonin reuptake inhibitor; antidepressant, anxiolytic, analgesic agent; neurodegenerative diseases; linking a cyclohexane-1,4-diamine with a carboxylic acid |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088032 Processes for the Preparation of Benzoimidazole Derivatives |
| 04/19/2007 | US20070088031 Novel chemical compounds |